In contrast, in B16-OVA melanoma tumor bearing model, c-Rel rather than Rel-A, was essential for the control of tumor growth and enhancement of anti-PD-1 treatment by impacting CD4+ Tconv (27). The gene discussed is REL; the disease is neoplasm.